| 2894- | HNK, | Pharmacological features, health benefits and clinical implications of honokiol |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 2895- | HNK, | Mitochondria-Targeted Honokiol Confers a Striking Inhibitory Effect on Lung Cancer via Inhibiting Complex I Activity |
| - | in-vitro, | Lung, | PC9 |
| 2896- | HNK, | Honokiol inhibits hypoxia-inducible factor-1 pathway |
| - | in-vivo, | Colon, | CT26 |
| 2897- | HNK, | Honokiol Inhibits Proliferation, Invasion and Induces Apoptosis Through Targeting Lyn Kinase in Human Lung Adenocarcinoma Cells |
| - | in-vitro, | Lung, | PC9 | - | in-vitro, | Lung, | A549 |
| 2898- | HNK, | Honokiol Suppression of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Gastric Cancer Cell Biological Activity and Its Mechanism |
| - | in-vitro, | GC, | AGS | - | in-vitro, | GC, | NCI-N87 | - | in-vitro, | BC, | MGC803 | - | in-vitro, | GC, | SGC-7901 |
| 2899- | HNK, | SIRT3 activator honokiol ameliorates surgery/anesthesia-induced cognitive decline in mice through anti-oxidative stress and anti-inflammatory in hippocampus |
| - | in-vivo, | Nor, | NA |
| 2901- | HNK, | doxoR, | Honokiol protects against doxorubicin cardiotoxicity via improving mitochondrial function in mouse hearts |
| - | in-vivo, | Nor, | NA |
| 8517- | HNK, | MAG, | Modulation of Rat Hepatic CYP1A and 2C Activity by Honokiol and Magnolol: Differential Effects on Phenacetin and Diclofenac Pharmacokinetics In Vivo |
| - | in-vivo, | Nor, | NA |
| 1021- | HNK, | Honokiol suppress the PD-L1 expression to improve anti-tumor immunity in lung cancer |
| - | in-vivo, | Lung, | NA |
| 1087- | HNK, | Honokiol Inhibits Non-Small Cell Lung Cancer Cell Migration by Targeting PGE2-Mediated Activation of β-Catenin Signaling |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Lung, | H1299 | - | in-vitro, | Lung, | H460 | - | in-vitro, | Lung, | H226 |
| 1119- | HNK, | Honokiol inhibits epithelial—mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E‐cadherin axis |
| - | vitro+vivo, | BC, | NA |
| 1120- | HNK, | Honokiol suppresses renal cancer cells' metastasis via dual-blocking epithelial-mesenchymal transition and cancer stem cell properties through modulating miR-141/ZEB2 signaling |
| - | vitro+vivo, | RCC, | NA |
| 1004- | HNK, | RAPA, | Honokiol downregulates PD-L1 expression and enhances antitumor effects of mTOR inhibitors in renal cancer cells |
| - | in-vitro, | RCC, | NA |
| 960- | HNK, | Honokiol Inhibits HIF-1α-Mediated Glycolysis to Halt Breast Cancer Growth |
| - | vitro+vivo, | BC, | MCF7 | - | vitro+vivo, | BC, | MDA-MB-231 |
| 1286- | HNK, | The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells |
| - | in-vitro, | CLL, | NA |
| 1153- | HNK, | Honokiol Eliminates Glioma/Glioblastoma Stem Cell-Like Cells via JAK-STAT3 Signaling and Inhibits Tumor Progression by Targeting Epidermal Growth Factor Receptor |
| - | in-vitro, | GBM, | U251 | - | in-vitro, | GBM, | U87MG | - | in-vivo, | NA, | NA |
| 1154- | HNK, | MET, | Honokiol inhibits the growth of hormone-resistant breast cancer cells: its promising effect in combination with metformin |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | SkBr3 | - | in-vitro, | BC, | MDA-MB-231 |
| 2081- | HNK, | Honokiol induces ferroptosis in colon cancer cells by regulating GPX4 activity |
| - | in-vitro, | Colon, | RKO | - | in-vitro, | Colon, | HCT116 | - | in-vitro, | Colon, | SW48 | - | in-vitro, | Colon, | HT-29 | - | in-vitro, | Colon, | LS174T | - | in-vitro, | Colon, | HCT8 | - | in-vitro, | Colon, | SW480 | - | in-vivo, | NA, | NA |
| 2071- | HNK, | Identification of senescence rejuvenation mechanism of Magnolia officinalis extract including honokiol as a core ingredient |
| - | Review, | Nor, | HaCaT |
| 2072- | HNK, | Honokiol Suppresses Cell Proliferation and Tumor Migration through ROS in Human Anaplastic Thyroid Cancer Cells |
| - | in-vitro, | Thyroid, | NA |
| 2073- | HNK, | Honokiol induces apoptosis and autophagy via the ROS/ERK1/2 signaling pathway in human osteosarcoma cells in vitro and in vivo |
| - | in-vitro, | OS, | U2OS | - | in-vivo, | NA, | NA |
| 2082- | HNK, | Revealing the role of honokiol in human glioma cells by RNA-seq analysis |
| - | in-vitro, | GBM, | U87MG | - | in-vitro, | GBM, | U251 |
| 2080- | HNK, | Honokiol Induces Ferroptosis by Upregulating HMOX1 in Acute Myeloid Leukemia Cells |
| - | in-vitro, | AML, | THP1 | - | in-vitro, | AML, | U937 | - | in-vitro, | AML, | SK-HEP-1 |
| 2079- | HNK, | Honokiol Microemulsion Causes Stage-Dependent Toxicity Via Dual Roles in Oxidation-Reduction and Apoptosis through FoxO Signaling Pathway |
| - | in-vitro, | Nor, | PC12 |
| 4241- | HNK, | Effects of Honokiol on Neurological Injury and Cognitive Function in Mice with Intracerebral Hemorrhage by Regulating BDNF-TrkB-CREB Signaling Pathway |
| - | in-vivo, | Stroke, | NA |
| - | in-vivo, | AD, | NA |
| 4239- | HNK, | Honokiol reverses depressive-like behavior and decrease in brain BDNF levels induced by chronic corticosterone injections in mice |
| - | in-vivo, | AD, | NA |
| 4238- | HNK, | Neuropharmacological potential of honokiol and its derivatives from Chinese herb Magnolia species: understandings from therapeutic viewpoint |
| - | Review, | AD, | NA | - | NA, | Park, | NA |
| - | in-vitro, | CRC, | HCT116 | - | in-vitro, | CRC, | LoVo | - | in-vivo, | CRC, | HCT116 |
| 4522- | HNK, | MAG, | Honokiol Is More Potent than Magnolol in Reducing Head and Neck Cancer Cell Growth |
| - | in-vitro, | HNSCC, | FaDu |
| 4688- | HNK, | Honokiol Suppresses Renal Cancer Cells’ Metastasis via Dual-Blocking Epithelial-Mesenchymal Transition and Cancer Stem Cell Properties through Modulating miR-141/ZEB2 Signaling |
| - | vitro+vivo, | RCC, | A498 |
| 4659- | HNK, | Honokiol Eliminates Human Oral Cancer Stem-Like Cells Accompanied with Suppression of Wnt/β-Catenin Signaling and Apoptosis Induction |
| - | in-vitro, | Oral, | NA |
| 7374- | HOO, | Exploring Ozonated Vegetable Oils as Antimicrobial and Functional Agents in Food Systems: A Systematic Narrative Review |
| - | Review, | Nor, | NA |
| 7373- | HOO, | Effects of topical ozonated olive oil on lipid profile, quality of life, wound healing and glycemic control in patients with diabetic foot ulcers: a randomized controlled trial |
| - | Trial, | Diabetic, | NA |
| 7371- | HOO, | Phytochemical characterization of peanut oil and its ozonized form to explore biological activities in vitro |
| - | in-vitro, | Colon, | NA |
| 7372- | HOO, | Ozone-modified properties of pumpkin seed oil as anti-H. pylori, anticancer, anti-diabetic and anti-obesity agent |
| - | in-vitro, | Pca, | PC3 |
| 7472- | Hops, | Modulation of breast cancer cell survival by aromatase inhibiting hop (Humulus lupulus L.) flavonoids |
| - | in-vitro, | BC, | SkBr3 |
| 7469- | Hops, | CHEMOPREVENTIVE PROPERTIES OF SPENT HOPS (HUMULUS LUPULUS L.) EXTRACT AGAINST ANGIOGENESIS, INVASION AND MIGRATION OF COLORECTAL CANCER CELLS |
| - | in-vitro, | CRC, | SW48 | - | in-vitro, | CRC, | HT29 |
| 7470- | Hops, | Hops (Humulus lupulus) inhibits oxidative estrogen metabolism and estrogen-induced malignant transformation in human mammary epithelial cells (MCF-10A) |
| - | in-vitro, | Nor, | MCF10 |
| 7471- | Hops, | Spent hops (Humulus Lupulus L.) extract as modulator of the inflammatory response in lipopolysaccharide stimulated RAW 264.7 macrophages |
| - | in-vitro, | Nor, | RAW264.7 |
| - | Review, | Var, | NA |
| 7651- | HPT, | Rad, | Hyperthermia inhibits homologous recombination repair and sensitizes cells to ionizing radiation in a time- and temperature-dependent manner |
| - | in-vitro, | Var, | NA |
| 7650- | HPT, | Hyperthermia and radiation therapy for locally advanced or recurrent breast cancer |
| - | Trial, | BC, | NA |
| - | in-vivo, | Laryn, | FaDu |
| 7619- | HPT, | The role of hyperthermia in the treatment of tumor |
| - | Review, | Var, | NA |
| 7624- | HPT, | Chemo, | A multicentre randomised clinical trial of chemoradiotherapy plus hyperthermia versus chemoradiotherapy alone in patients with locally advanced cervical cancer |
| - | Trial, | Cerv, | NA |
| 7618- | HPT, | ESHO 2-85. Hyperthermia as an adjuvant to radiation therapy in the treatment of advanced neck nodes: A randomized multicenter study by the European Society for Hyperthermic Oncology |
| - | Trial, | HNSCC, | NA |
| 7599- | HPT, | Rad, | Recent development on hyperthermia: An effective cotreatment improving radiotherapy outcome |
| - | Review, | Var, | NA |
| 7598- | HPT, | Rad, | Chemo, | The role of capacitive hyperthermia as an adjunct treatment in oncology: a systematic review of randomized phase III trials |
| - | Review, | Var, | NA |
| 7620- | HPT, | Hyperthermia and radiotherapy: physiological basis for a synergistic effect |
| - | Review, | Var, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid